Picture your Future. Save for it by earning 1.5% on a 1-year Term Deposit Account! Learn more.

Notes from the Trading Desk – Franklin Templeton

Franklin Templeton’s Notes from the Trading Desk offers a weekly overview of what their professional traders and analysts are watching in the markets. The European desk is manned by eight professionals based in Edinburgh, Scotland, with an average of 15 years of experience whose job it is to monitor the markets around the world. Their views are theirs alone and are not intended to be construed as investment advice.

The Digest

Markets were expected to be quiet last week as US investors took Thanksgiving vacations, but news of the COVID-19 variant that emerged in South Africa (named Omicron) shook sentiment on Friday, prompting sharp declines. With that, we saw some significant weekly moves; the MSCI World Index was down 2.7%, the European Stoxx 600 Index was down 4.5% (its worst weekly performance since 2020), the S&P 500 Index down 2.2% and the MSCI Asia Pacific Index continued with its underperformance, down 2.9%.

Omicron Variant Threat Spooks Investors

Equity markets plunged last Friday on the Omicron (B.1.1.529) COVID-19 variant headlines, as there were concerns it has a high number of mutations in the spike protein (reducing vaccines ability to recognise and fight it off) and the variant is more transmissible than the previous Delta variant. The Financial Times reported that early PCR results suggest 90% of 1,100 new cases last Wednesday in the Gauteng region of South Africa (Johannesburg) were caused by the new variant. The rapid spread of new cases prompted the United Kingdom into action, with travel bans on six African countries. The UK Health Security Agency said it was the “most worrying” variant yet.

Since this news broke, a growing number of countries have confirmed cases of Omicron and further travel restrictions are being put in place; Japan announced it was closing its borders to foreign travelers once again. Regarding the virus, it is reported that some South African health officials suggested “no unusual symptoms have been reported following infection with the B.1.1.529 variant and as with other variants some individuals are asymptomatic”. It is also reassuring Moderna is trading up 10% pre-market after saying that a vaccine will be ready early next year.

However, details at this stage remain light and it thought it could take around two weeks for scientists to fully understand Omicron.

Market Reaction

Asian markets were the first to fall sharply last Friday, with Hong Kong’s Hang Seng Index down 2.7% and Japan’s Nikkei Index down 2.5%, the worst-performing markets in that region. Europe followed suit, with the European Stoxx 600 Index seeing its worst weekly performance since October 2020, with the index finishing down 4.5% and every single subsector down on the week. The European Volatility Index rose 63%.

Nerves regarding the COVID-19 situation in Europe were already brittle, given the rising cases in many countries and fresh lockdown measures being enforced or discussed, so Friday’s news prompted a further sharp unwind in the travel and leisure space; “stay at home” stocks held up well, down just 0.5% Friday, while “reopening” stocks slumped 9.4%. In addition, banks and oil and gas also lagged as the recent rotation into value comes to a halt. West Texas Intermediate crude oil fell 13% Friday on fears fresh travel restrictions may dent demand for crude oil. No surprise to see defensive sectors outperform in such a risk-off environment, with utilities and health care outperforming.

The risk-off theme was clear across asset classes, with the US 10-year Treasury yield tightening by around 15 basis points (bps) to 1.47%, one of the yield’s sharpest declines in recent times. In the foreign exchange markets, the Japanese yen and Swiss franc strengthened, and elsewhere, credit spreads also widened as the news hit corporate default swaps.

While we saw some extreme moves, it is important to note that a huge number of market participants were on holiday due to the US Thanksgiving break last week. While it is hard to quantify the impact, it is likely that volatility was exacerbated because many US market participants were out. However, European market volumes were high, as Friday saw the third-highest daily volume of the year in the Stoxx 600 Index. Of note, there was a clear unwind of crowded trades.

The dust seems to be settling a bit on Friday’s moves, and markets have steadied somewhat in early trade this week. In Asia, we saw muted moves lower with Hong Kong’s equity market down 1%, South Korea’s down 0.9% and Shanghai market in China unchanged on the day. Japan was the laggard, down 1.6% on the news of the travel ban. The European Stoxx 600 Index held up well, with some respite for the hardest-hit names, including travel and leisure. The US 10-year Treasury yield widened to 1.53%.

Looking ahead, it will be important to watch how this latest COVID news feeds into central bank thinking, with money markets already repriced the timeline for potential rate hikes further out.

The Week in Review


European equities experienced their worst one-day move of the year to close last week down 4.5%. We saw classic “risk off” trade, as the market digested the news of the latest Omicron variant. Bonds caught a bid, the Japanese yen and Swiss franc were stronger, and commodities were lower.

The detail regarding the mutation of the virus was fairly vague, but that didn’t stop investors from becoming spooked by the headlines. The lack of market participants and US market closures due to the Thanksgiving holiday likely exacerbated the moves. Right now, we don’t know what this mutation means for vaccine effectiveness or transmissibility.

Investors in Europe were already on tenterhooks these past few weeks following the rise in cases around Europe, so it did not take much for sentiment to be shaken further. Volatility spiked in Europe on Friday, with the European Volatility Index (V2X) up 63% on the day and passed 30 for the first time since January. Note, the index peaked >80 back in March 2020.

We saw a clear rotation out of cyclicals last week as investors flocked to safety. Another clear theme, for obvious reasons, was selling of the reopening trade. The “going out” basket closed lower as travel and leisure names were particularly hard hit. Concerns around international travel deteriorated further with the news of the new COVID-19 variant, causing European airlines to extend losses. Bank stocks also suffered. Defensive names including utilities and telecommunications, along with food and beverage, were unsurprisingly the “winners” last week—albeit all still with mile losses overall. Friday was also the worst day year-to-date for oil prices. Brent crude oil was down 10.3% on the day at Friday’s equity market close (down 6.6% on the week).

Looking to politics, there are a couple of interest dynamics in Europe to keep an eye on.

German Politics: The Social Democratic Party (SPD), Free Democratic Party (FDP) and the Greens unveiled the new government coalition. They now must get the approval of their party members and then it is likely they will take power around 9 December. Former Finance Minister Olaf Scholz (SPD) will replace Angela Merkel as Chancellor; FDP leader Christian Lindner will be finance minister; and the Greens leader, Annalena Baerbock, will be foreign minister.

One area that will be interesting is foreign policy, with Baerbock already taking a tougher stance on both China and Russia. She stated German foreign policy should be “guided by human rights and values” and “We have to stop (equating) German interests with German economic interests”. Perhaps something to watch for those companies with significant Chinese exposure.

UK Politics: After a few torrid weeks for Prime Minister Boris Johnson (party scandal, migrant crisis, European Union loggerheads on Northern Ireland, the now infamous Confederation of British Industry speech incident, etc.) support for the Conservative party in the polls has waned somewhat. Last week, we highlighted cautious UK investor sentiment, (Bank of America Survey, UK equity fund outflows) and whilst it’s too soon to read too much into the polling, if it continues it will be interesting to see how this impacts investors’ view on the United Kingdom.

United States

Given the Thanksgiving holiday last Thursday and half day on Friday, it was a quieter week for US markets in terms of newsflow. Friday’s Omicron variant selloff was the main talking point. Last week, the S&P 500 Index traded down 2.2%. As in Europe, the defensive stocks held up fairly well, with mild losses in utilities and consumer staples and communications services and consumer discretionary faring a bit worse.

Earlier in the week, US President Joe Biden reaffirmed current Federal Reserve (Fed) President Jerome Powell for another term, with Lael Brainard nominated as vice chair. The news prompted some sharp moves in the bond markets, with the US 10-year yield widening to 1.62% last Monday.

Some believe that Powell will now have greater flexibility to become more hawkish, as Brainard—who was in the running for the Fed leadership role—is seen as more dovish. With the move in yields, we did see growth/tech names underperform earlier last week. It remains to be seen how the latest COVID news will impact policymakers—and markets—going forward.

Looking at Fedspeak, there appears to be more noise around a potential acceleration in the tapering of the Fed’s asset purchasing programme. Atlanta Fed Chief Raphael Bostic had argued in favour of a faster pace of tightening to give the Federal Open Market Committee more optionality. In addition, the Fed meeting minutes released last week said the Fed stressed the need to be flexible as it winds down its US$120 billion-a-month bond-buying programme. However, how the recent COVID-19 news flow feeds into this will be something to watch.

Finally, it is worth noting that given the moves on Friday, the CNN Fear & Greed investor sentiment Index has plunged firmly into “Fear” territory. The change in sentiment looks extreme and, if we get any reassuring headlines regarding the Omicron variant, expect a sharp bounce back.

Asia and Pacific

What we thought might be quieter week in Asia (US holidays, Japan was closed on Tuesday) turned out to be rather busier than expected, as the new COVID-19 Omicron variant headlines spooked the market at the end of the week and the old theme of China vs. United States continued.

China: Chinese markets weakened slightly last week amid US-China tensions and rising economic pressures that raised expectations for supportive government measures. The yield on China’s 10-year government bond fell to 2.881% from the prior week’s 2.946% as investors sought safe-haven assets.

Relations with the United States remained tense over the status of Taiwan and trade issues. The US Commerce Department issued a trade blacklist naming a dozen Chinese companies that it said supported the military modernisation of the People’s Liberation Army. In response, a Chinese official said the United States should not expect China’s military to compromise regarding Taiwan.

On the economic front, Premier Li Keqiang said that China should step up efforts to stabilise employment, financing, and other key areas and that the government was studying policies on tax and fee cuts, along with some reforms, to support businesses.

Hong Kong: Stocks traded down this week with internet and health care dragging the market lower, with focus on the Hang Seng Index and Hang Sang Composite Index quarterly review results. Internet names were weak due to news around “data tax” against platform developers and tighten regulations via tax on “flux economy” participants.

According to an official, the recent detection of three imported cases of COVID-19 caused by the Omicron variant in Hong Kong won’t affect the city’s reopening plans with mainland China.

South Korea: The KOSPI Index traded higher last week, with large-capitalisation stocks taking the lead (especially the semiconductors) on the back of strong earnings reported by US competitors MICRON, NVIDIA, etc. The Bank of Korea raised its benchmark rate by 25 basis points, but this was well flagged and so no material impact on the markets.

Japan: Japanese equities held up for much of the shortened week, only to succumb late last week amid worries about the pace of economic recovery in light of the new COVID variant. The Nikkei 225 Index fell below 29,000, shedding 3.3%.

Looking at macro data, flash data showed the Japan Composite Purchasing Managers’ Index (PMI) rose to 52.5 in November—a 37-month high—from 50.7 in October, buoyed by loosening coronavirus restrictions at that time, and soaring vaccination rates. Similarly, the Japan Services PMI hit a 26-month high of 52.1 in November, up from 50.7 the previous month. Japan’s Manufacturing PMI rose to 54.2 in November, up from 53.2 in October.

The Week Ahead

Unfortunately, we are back to watching the latest COVID-19 headlines when following market sentiment. However, Fed policy will be worth watching too as Powell speaks this week. The October US employment report is also a focal point. In Europe, inflation data will be in focus as we get Consumer Price Index (CPI) data.

Monday 29 November:

  • Spain CPI
  • UK net consumer credit
  • Eurozone consumer confidence
  • Germany CPI
  • Italy Producer Price Index (PPI)
  • US pending home sales

Tuesday 30 November:    

  • UK nationwide house price survey
  • France gross domestic product (GDP), CPI and consumer spending
  • Germany unemployment change
  • Spain current account balance
  • Italy GDP
  • Eurozone CPI

Wednesday 1 December:

  • Switzerland CPI
  • Germany PMI manufacturing
  • Italy PMI manufacturing, budget balance
  • UK PMI manufacturing
  • US PMI Manufacturing, MBA mortgage applications, ADP employment change, Institute for Supply Management (ISM) manufacturing

Thursday 2 December:     

  • Spain unemployment change
  • Italy unemployment rate
  • US challenger layoffs
  • US jobless claims

Friday 3 December:    

  • France manufacturing and industrial production
  • Eurozone retail sales
  • Germany PMI Services/composite
  • Italy PMI services/composite
  • UK PMI services/composite
  • US non-farm payrolls & unemployment rate


Franklin Templeton Key risks & Disclaimers:

What Are the Risks?

All investments involve risk, including possible loss of principal. The value of investments can go down as well as up, and investors may not get back the full amount invested. Stock prices fluctuate, sometimes rapidly and dramatically, due to factors affecting individual companies, particular industries or sectors, or general market conditions. Bond prices generally move in the opposite direction of interest rates. Thus, as prices of bonds in an investment portfolio adjust to a rise in interest rates, the value of the portfolio may decline. Investments in foreign securities involve special risks including currency fluctuations, economic instability and political developments. Investments in developing markets involve heightened risks related to the same factors, in addition to those associated with their relatively small size and lesser liquidity. Past performance is not an indicator or guarantee of future performance.

This article reflects the analysis and opinions of Franklin Templeton’s European Trading Desk as of 29th November 2021, and may vary from the analysis and opinions of other investment teams, platforms, portfolio managers or strategies at Franklin Templeton. Because market and economic conditions are often subject to rapid change, the analysis and opinions provided may change without notice. An assessment of a particular country, market, region, security, investment or strategy is not intended as an investment recommendation, nor does it constitute investment advice. Statements of fact are from sources considered reliable, but no representation or warranty is made as to their completeness or accuracy. This article does not provide a complete analysis of every material fact regarding any country, region, market, industry or security. Nothing in this document may be relied upon as investment advice or an investment recommendation. The companies named herein are used solely for illustrative purposes; any investment may or may not be currently held by any portfolio advised by Franklin Templeton. Data from third-party sources may have been used in the preparation of this material and Franklin Templeton (“FT”) has not independently verified, validated or audited such data. FT accepts no liability whatsoever for any loss arising from use of this information and reliance upon the comments, opinions and analyses in the material is at the sole discretion of the user. Products, services and information may not be available in all jurisdictions and are offered by FT affiliates and/or their distributors as local laws and regulations permit. Please consult your own professional adviser for further information on availability of products and services in your jurisdiction. 

Issued by Franklin Templeton Investment Management Limited (FTIML) Registered office: Cannon Place, 78 Cannon Street, London EC4N 6HL. FTIML is authorised and regulated by the Financial Conduct Authority.

MeDirect Disclaimers:

This information has been accurately reproduced, as received from Franklin Templeton Investment Management Limited (FTIML). No information has been omitted which would render the reproduced information inaccurate or misleading. This information is being distributed by MeDirect Bank (Malta) plc to its customers. The information contained in this document is for general information purposes only and is not intended to provide legal or other professional advice nor does it commit MeDirect Bank (Malta) plc to any obligation whatsoever. The information available in this document is not intended to be a suggestion, recommendation or solicitation to buy, hold or sell, any securities and is not guaranteed as to accuracy or completeness.

The financial instruments discussed in the document may not be suitable for all investors and investors must make their own informed decisions and seek their own advice regarding the appropriateness of investing in financial instruments or implementing strategies discussed herein.

If you invest in this product you may lose some or all of the money you invest. The value of your investment may go down as well as up. A commission or sales fee may be charged at the time of the initial purchase for an investment. Any income you get from this investment may go down as well as up. This product may be affected by changes in currency exchange rate movements thereby affecting your investment return therefrom. The performance figures quoted refer to the past and past performance is not a guarantee of future performance or a reliable guide to future performance. Any decision to invest in a mutual fund should always be based upon the details contained in the Prospectus and Key Investor Information Document (KIID), which may be obtained from MeDirect Bank (Malta) plc.

Join MeDirect today to access the tools you need to put your money to work on your own terms.

Latest news articles

BlackRock - Why we keep leaning into risk
All News

BlackRock Commentary: Why we keep leaning into risk

Investment opportunities are emerging amid a unique macroeconomic backdrop, with U.S. equities leading gains, particularly driven by AI-related companies, and expectations of continued volatility. The focus is on overweight positions in U.S., UK, and Japan stocks, while favoring quality short-term fixed income and private credit investments.

Epic Investment Partners Weekly Article
All News

Epic Investment Partners Views: The Week Ahead

This week’s key events include China’s Third Plenum, the ECB rate decision, US bank earnings, and several significant economic data releases from the US, Eurozone, and UK.. Last week, Fed Chair Powell highlighted progress on inflation but emphasised caution in rate cuts, while China’s economic recovery showed signs of weakness with lower-than-expected inflation and GDP growth.

Experience better Banking

The sooner you start managing your money, your way, using the best-in-class tools, the sooner you’ll see results. 

Sign up and open your account for free, within minutes.



We strive to ensure a streamlined account opening process, via a structured and clear set of requirements and personalised assistance during the initial communication stages. If you are interested in opening a corporate account with MeDirect, please complete an Account Opening Information Questionnaire and send it to corporate@medirect.com.mt.

For a comprehensive list of documentation required to open a corporate account please contact us by email at corporate@medirect.com.mt or by phone on (+356) 2557 4444.